Eplerenone
Sold as Eplerenone unicorn, Eplerenone kiara, Plerintra, Prasinel, Inspra
Methyl (1R,2S,9R,10R,11S,14R,15S,17R)-2,15-dimethyl-5,5'-dioxospiro[18-oxapentacyclo[8.8.0.01,17.02,7.011,15]octadec-6-ene-14,2'-oxolane]-9-carboxylate
Drag to rotate. Structure from PubChem CID 443872.
Background
Registration
- Applicants
- 4
- Registrations
- 10
- Schedule source
- Consolidated Schedules 06 July 2026
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Unicorn Pharmaceuticals (Pty) Ltd | Eplerenone unicorn | 25, 50 | 560544, 560545 | S4 | None |
| Kiara Health (Pty) Ltd | Eplerenone kiara | 25, 50 | 560967, 560968 | S4 | None |
| Hetero Drugs South Africa (Pty) Ltd | Plerintra, Prasinel | 25 mg, 50 mg | 570052, 570053, 570054.052, 570055.053 | S4 | None |
| Viatris Healthcare (Pty) LtdCertificate held by Upjohn South Africa (Pty) Ltd | Inspra | 25, 50 | A390106, A390107 | S4 | PIPIL |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Eplerenone 25 unicorn EACH TABLET CONTAINS EPLERENONE 25,0 mg | 25 | 56054456/6.4/0544 | Registered | S4 | None |
| Eplerenone 50 unicorn EACH TABLET CONTAINS EPLERENONE 50,0 mg | 50 | 56054556/6.4/0545 | Registered | S4 | None |
| Eplerenone 25 kiara EACH TABLET CONTAINS EPLERENONE 25,0 mg | 25 | 56096756/6.5/0967 | Registered | S4 | None |
| Eplerenone 50 kiara EACH TABLET CONTAINS EPLERENONE 50,0 mg | 50 | 56096856/6.5/0968 | Registered | S4 | None |
| Plerintra 25 MG EACH TABLET CONTAINS: EPLERENONE 25,0 mg | 25 mg | 57005257/6.4/0052 | Registered | S4 | None |
| Plerintra 50 MG EACH TABLET CONTAINS: EPLERENONE 50,0 mg | 50 mg | 57005357/6.4/0053 | Registered | S4 | None |
| Prasinel 25 MG EACH TABLET CONTAINS: EPLERENONE 25,0 mg | 25 mg | 570054.05257/6.4/0054.052 | Registered | S4 | None |
| Prasinel 50 MG EACH TABLET CONTAINS: EPLERENONE 50,0 mg | 50 mg | 570055.05357/6.4/0055.053 | Registered | S4 | None |
| Inspra 25 EACH TABLET CONTAINS EPLERENONE 25,0 mg | 25Film-coated tablet | A390106A39/6.4/0106Approved 11 October 2022 | Registered | S4 | PIPIL |
| Inspra 50 EACH TABLET CONTAINS EPLERENONE 50,0 mg | 50Film-coated tablet | A390107A39/6.4/0107Approved 11 October 2022 | Registered | S4 | PIPIL |
Regulatory status
Where S4 sits on the scale
Prescription-only medicine.
Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S4, matched to the Consolidated Schedules by ingredient, confidence high.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
Consolidated Schedules listings for Eplerenone
S4: Eplerenone
Consolidated Schedules 06 July 2026, line 6209
Pharmacological class: Antidysrhythmics /conduction modifying medicines. (class 6.4)
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
Schedule Verification
Inspra 25, Viatris Healthcare (Pty) Ltd is scheduled S4 in its official SAHPRA documents, read with 90% confidence.
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.